$LBML.OB Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AKESIS PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AKESIS PHARMACEUTICALS, INC.. Get notifications about new insider transactions in AKESIS PHARMACEUTICALS, INC. for free.
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 16 2008 | LBML.OB | AKESIS PHARMACEUTI ... | Fine Stuart A | Buy | P | 0.49 | 5,000 | 2,450 | 202,401 | 197.4 K to 202.4 K (+2.53 %) | |
Oct 16 2008 | LBML.OB | AKESIS PHARMACEUTI ... | Fine Stuart A | Buy | P | 0.93 | 42,101 | 39,154 | 197,401 | 155.3 K to 197.4 K (+27.11 %) | |
Oct 16 2008 | LBML.OB | AKESIS PHARMACEUTI ... | Fine Stuart A | Buy | P | 0.85 | 19,000 | 16,150 | 155,300 | 136.3 K to 155.3 K (+13.94 %) | |
Oct 16 2008 | LBML.OB | AKESIS PHARMACEUTI ... | Fine Stuart A | Buy | P | 0.80 | 2,500 | 2,000 | 136,300 | 133.8 K to 136.3 K (+1.87 %) | |
Oct 16 2008 | LBML.OB | AKESIS PHARMACEUTI ... | Fine Stuart A | Buy | P | 0.95 | 110,050 | 104,548 | 133,800 | 23.8 K to 133.8 K (+463.37 %) | |
Oct 16 2008 | LBML.OB | AKESIS PHARMACEUTI ... | Fine Stuart A | Buy | P | 0.94 | 11,250 | 10,575 | 23,750 | 12.5 K to 23.8 K (+90.00 %) | |
Oct 16 2008 | LBML.OB | AKESIS PHARMACEUTI ... | Fine Stuart A | Buy | P | 0.80 | 2,500 | 2,000 | 12,500 | 10 K to 12.5 K (+25.00 %) | |
Oct 16 2008 | LBML.OB | AKESIS PHARMACEUTI ... | Fine Stuart A | Buy | P | 0.78 | 10,000 | 7,800 | 10,000 | 0 to 10 K | |
Jun 20 2008 | LBML.OB | AKESIS PHARMACEUTI ... | Lichter Jay | President and CEO | Option Exercise | A | 0.66 | 500,000 | 330,000 | 1,500,000 | |
Jun 20 2008 | LBML.OB | AKESIS PHARMACEUTI ... | Lichter Jay | President and CEO | Option Exercise | A | 0.51 | 500,000 | 255,000 | 1,500,000 | |
Jun 20 2008 | LBML.OB | AKESIS PHARMACEUTI ... | Hendrick John T | CFO and Secretary | Option Exercise | A | 0.66 | 125,000 | 82,500 | 375,000 | |
Mar 27 2008 | LBML.OB | AKESIS PHARMACEUTI ... | Avalon Ventures VII L P | 10% Owner | Option Exercise | A | 0.85 | 352,941 | 300,000 | 1,102,941 | |
Mar 27 2008 | LBML.OB | AKESIS PHARMACEUTI ... | Avalon Ventures VII L P | 10% Owner | Buy | P | 0.85 | 2,352,942 | 2,000,001 | 7,670,442 | 5.3 M to 7.7 M (+44.25 %) |
Mar 27 2008 | LBML.OB | AKESIS PHARMACEUTI ... | Kinsella Kevin J | Director | Option Exercise | A | 0.85 | 352,941 | 300,000 | 1,127,941 | |
Mar 27 2008 | LBML.OB | AKESIS PHARMACEUTI ... | Kinsella Kevin J | Director | Buy | P | 0.85 | 2,352,942 | 2,000,001 | 10,504,717 | 8.2 M to 10.5 M (+28.86 %) |
Nov 21 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Avalon Ventures VII L P | 10% Owner | Buy | P | 0.73 | 10,000 | 7,300 | 5,317,500 | 5.3 M to 5.3 M (+0.19 %) |
Nov 21 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Avalon Ventures VII L P | 10% Owner | Buy | P | 0.72 | 10,000 | 7,200 | 5,317,500 | 5.3 M to 5.3 M (+0.19 %) |
Nov 21 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Kinsella Kevin J | Director | Buy | P | 0.73 | 10,000 | 7,300 | 8,151,775 | 8.1 M to 8.2 M (+0.12 %) |
Nov 21 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Kinsella Kevin J | Director | Buy | P | 0.72 | 10,000 | 7,200 | 8,151,775 | 8.1 M to 8.2 M (+0.12 %) |
Sep 14 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Kinsella Kevin J | Director | Buy | P | 0.67 | 2,500 | 1,675 | 8,131,775 | 8.1 M to 8.1 M (+0.03 %) |
Sep 14 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Kinsella Kevin J | Director | Buy | P | 0.65 | 5,000 | 3,250 | 8,131,775 | 8.1 M to 8.1 M (+0.06 %) |
Sep 14 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Kinsella Kevin J | Director | Buy | P | 0.59 | 5,000 | 2,950 | 8,131,775 | 8.1 M to 8.1 M (+0.06 %) |
Sep 14 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Kinsella Kevin J | Director | Buy | P | 0.55 | 5,000 | 2,750 | 8,131,775 | 8.1 M to 8.1 M (+0.06 %) |
Sep 14 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Kinsella Kevin J | Director | Buy | P | 0.55 | 5,000 | 2,750 | 8,131,775 | 8.1 M to 8.1 M (+0.06 %) |
Sep 14 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Avalon Ventures VII L P | 10% Owner | Buy | P | 0.67 | 2,500 | 1,675 | 5,297,500 | 5.3 M to 5.3 M (+0.05 %) |
Sep 14 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Avalon Ventures VII L P | 10% Owner | Buy | P | 0.65 | 5,000 | 3,250 | 5,297,500 | 5.3 M to 5.3 M (+0.09 %) |
Sep 14 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Avalon Ventures VII L P | 10% Owner | Buy | P | 0.59 | 5,000 | 2,950 | 5,297,500 | 5.3 M to 5.3 M (+0.09 %) |
Sep 14 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Avalon Ventures VII L P | 10% Owner | Buy | P | 0.55 | 5,000 | 2,750 | 5,297,500 | 5.3 M to 5.3 M (+0.09 %) |
Sep 14 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Avalon Ventures VII L P | 10% Owner | Buy | P | 0.55 | 5,000 | 2,750 | 5,297,500 | 5.3 M to 5.3 M (+0.09 %) |
Sep 12 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Kinsella Kevin J | Director | Buy | P | 0.53 | 7,500 | 3,975 | 8,109,275 | 8.1 M to 8.1 M (+0.09 %) |
Sep 12 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Kinsella Kevin J | Director | Buy | P | 0.50 | 5,000 | 2,500 | 8,109,275 | 8.1 M to 8.1 M (+0.06 %) |
Sep 12 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Kinsella Kevin J | Director | Buy | P | 0.50 | 5,000 | 2,500 | 8,109,275 | 8.1 M to 8.1 M (+0.06 %) |
Sep 12 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Kinsella Kevin J | Director | Buy | P | 0.50 | 5,000 | 2,500 | 8,109,275 | 8.1 M to 8.1 M (+0.06 %) |
Sep 12 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Kinsella Kevin J | Director | Buy | P | 0.50 | 5,000 | 2,500 | 8,109,275 | 8.1 M to 8.1 M (+0.06 %) |
Sep 12 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Kinsella Kevin J | Director | Buy | P | 0.55 | 2,500 | 1,375 | 8,109,275 | 8.1 M to 8.1 M (+0.03 %) |
Sep 12 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Kinsella Kevin J | Director | Buy | P | 0.55 | 2,500 | 1,375 | 8,109,275 | 8.1 M to 8.1 M (+0.03 %) |
Sep 12 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Kinsella Kevin J | Director | Buy | P | 0.55 | 2,500 | 1,375 | 8,109,275 | 8.1 M to 8.1 M (+0.03 %) |
Sep 12 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Kinsella Kevin J | Director | Buy | P | 0.55 | 2,500 | 1,375 | 8,109,275 | 8.1 M to 8.1 M (+0.03 %) |
Sep 12 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Avalon Ventures VII L P | 10% Owner | Buy | P | 0.53 | 7,500 | 3,975 | 5,275,000 | 5.3 M to 5.3 M (+0.14 %) |
Sep 12 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Avalon Ventures VII L P | 10% Owner | Buy | P | 0.50 | 5,000 | 2,500 | 5,275,000 | 5.3 M to 5.3 M (+0.09 %) |
Sep 12 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Avalon Ventures VII L P | 10% Owner | Buy | P | 0.50 | 5,000 | 2,500 | 5,275,000 | 5.3 M to 5.3 M (+0.09 %) |
Sep 12 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Avalon Ventures VII L P | 10% Owner | Buy | P | 0.50 | 5,000 | 2,500 | 5,275,000 | 5.3 M to 5.3 M (+0.09 %) |
Sep 12 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Avalon Ventures VII L P | 10% Owner | Buy | P | 0.50 | 5,000 | 2,500 | 5,275,000 | 5.3 M to 5.3 M (+0.09 %) |
Sep 12 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Avalon Ventures VII L P | 10% Owner | Buy | P | 0.55 | 2,500 | 1,375 | 5,275,000 | 5.3 M to 5.3 M (+0.05 %) |
Sep 12 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Avalon Ventures VII L P | 10% Owner | Buy | P | 0.55 | 2,500 | 1,375 | 5,275,000 | 5.3 M to 5.3 M (+0.05 %) |
Sep 12 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Avalon Ventures VII L P | 10% Owner | Buy | P | 0.55 | 2,500 | 1,375 | 5,275,000 | 5.3 M to 5.3 M (+0.05 %) |
Sep 12 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Avalon Ventures VII L P | 10% Owner | Buy | P | 0.55 | 2,500 | 1,375 | 5,275,000 | 5.3 M to 5.3 M (+0.05 %) |
Sep 10 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Kinsella Kevin J | Director | Buy | P | 0.48 | 5,000 | 2,400 | 8,071,775 | 8.1 M to 8.1 M (+0.06 %) |
Sep 10 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Kinsella Kevin J | Director | Buy | P | 0.49 | 5,000 | 2,450 | 8,071,775 | 8.1 M to 8.1 M (+0.06 %) |
Sep 10 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Kinsella Kevin J | Director | Buy | P | 0.48 | 5,000 | 2,400 | 8,071,775 | 8.1 M to 8.1 M (+0.06 %) |
Sep 10 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Kinsella Kevin J | Director | Buy | P | 0.46 | 5,000 | 2,300 | 8,071,775 | 8.1 M to 8.1 M (+0.06 %) |
Sep 10 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Avalon Ventures VII L P | 10% Owner | Buy | P | 0.48 | 5,000 | 2,400 | 5,237,500 | 5.2 M to 5.2 M (+0.10 %) |
Sep 10 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Avalon Ventures VII L P | 10% Owner | Buy | P | 0.49 | 5,000 | 2,450 | 5,237,500 | 5.2 M to 5.2 M (+0.10 %) |
Sep 10 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Avalon Ventures VII L P | 10% Owner | Buy | P | 0.48 | 5,000 | 2,400 | 5,237,500 | 5.2 M to 5.2 M (+0.10 %) |
Sep 10 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Avalon Ventures VII L P | 10% Owner | Buy | P | 0.46 | 5,000 | 2,300 | 5,237,500 | 5.2 M to 5.2 M (+0.10 %) |
Sep 06 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Kinsella Kevin J | Director | Buy | P | 0.49 | 5,000 | 2,450 | 8,051,775 | 8 M to 8.1 M (+0.06 %) |
Sep 06 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Kinsella Kevin J | Director | Buy | P | 0.47 | 5,000 | 2,350 | 8,051,775 | 8 M to 8.1 M (+0.06 %) |
Sep 06 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Kinsella Kevin J | Director | Buy | P | 0.47 | 5,000 | 2,350 | 8,051,775 | 8 M to 8.1 M (+0.06 %) |
Sep 06 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Kinsella Kevin J | Director | Buy | P | 0.47 | 5,000 | 2,350 | 8,051,775 | 8 M to 8.1 M (+0.06 %) |
Sep 06 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Kinsella Kevin J | Director | Buy | P | 0.48 | 5,000 | 2,400 | 8,051,775 | 8 M to 8.1 M (+0.06 %) |
Sep 06 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Kinsella Kevin J | Director | Buy | P | 0.47 | 5,000 | 2,350 | 8,051,775 | 8 M to 8.1 M (+0.06 %) |
Sep 06 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Kinsella Kevin J | Director | Buy | P | 0.46 | 5,000 | 2,300 | 8,051,775 | 8 M to 8.1 M (+0.06 %) |
Sep 06 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Avalon Ventures VII L P | 10% Owner | Buy | P | 0.49 | 5,000 | 2,450 | 5,217,500 | 5.2 M to 5.2 M (+0.10 %) |
Sep 06 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Avalon Ventures VII L P | 10% Owner | Buy | P | 0.47 | 5,000 | 2,350 | 5,217,500 | 5.2 M to 5.2 M (+0.10 %) |
Sep 06 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Avalon Ventures VII L P | 10% Owner | Buy | P | 0.47 | 5,000 | 2,350 | 5,217,500 | 5.2 M to 5.2 M (+0.10 %) |
Sep 06 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Avalon Ventures VII L P | 10% Owner | Buy | P | 0.47 | 5,000 | 2,350 | 5,217,500 | 5.2 M to 5.2 M (+0.10 %) |
Sep 06 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Avalon Ventures VII L P | 10% Owner | Buy | P | 0.48 | 5,000 | 2,400 | 5,217,500 | 5.2 M to 5.2 M (+0.10 %) |
Sep 06 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Avalon Ventures VII L P | 10% Owner | Buy | P | 0.47 | 5,000 | 2,350 | 5,217,500 | 5.2 M to 5.2 M (+0.10 %) |
Sep 06 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Avalon Ventures VII L P | 10% Owner | Buy | P | 0.46 | 5,000 | 2,300 | 5,217,500 | 5.2 M to 5.2 M (+0.10 %) |
Sep 04 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Kinsella Kevin J | Director | Buy | P | 0.50 | 17,500 | 8,750 | 8,016,775 | 8 M to 8 M (+0.22 %) |
Sep 04 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Kinsella Kevin J | Director | Buy | P | 0.48 | 5,000 | 2,400 | 8,016,775 | 8 M to 8 M (+0.06 %) |
Sep 04 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Kinsella Kevin J | Director | Buy | P | 0.50 | 10,000 | 5,000 | 8,016,775 | 8 M to 8 M (+0.12 %) |
Sep 04 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Avalon Ventures VII L P | 10% Owner | Buy | P | 0.50 | 17,500 | 8,750 | 5,182,500 | 5.2 M to 5.2 M (+0.34 %) |
Sep 04 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Avalon Ventures VII L P | 10% Owner | Buy | P | 0.48 | 5,000 | 2,400 | 5,182,500 | 5.2 M to 5.2 M (+0.10 %) |
Sep 04 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Avalon Ventures VII L P | 10% Owner | Buy | P | 0.50 | 10,000 | 5,000 | 5,182,500 | 5.2 M to 5.2 M (+0.19 %) |
Aug 30 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Kinsella Kevin J | Director | Buy | P | 0.48 | 10,000 | 4,800 | 7,984,275 | 8 M to 8 M (+0.13 %) |
Aug 30 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Kinsella Kevin J | Director | Buy | P | 0.47 | 5,000 | 2,350 | 7,984,275 | 8 M to 8 M (+0.06 %) |
Aug 30 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Avalon Ventures VII L P | 10% Owner | Buy | P | 0.48 | 10,000 | 4,800 | 5,150,000 | 5.1 M to 5.2 M (+0.19 %) |
Aug 30 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Avalon Ventures VII L P | 10% Owner | Buy | P | 0.47 | 5,000 | 2,350 | 5,150,000 | 5.1 M to 5.2 M (+0.10 %) |
Aug 28 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Avalon Ventures VII L P | 10% Owner | Buy | P | 0.51 | 5,000 | 2,550 | 5,135,000 | 5.1 M to 5.1 M (+0.10 %) |
Aug 24 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Kinsella Kevin J | Director | Buy | P | 0.50 | 15,000 | 7,500 | 7,964,275 | 7.9 M to 8 M (+0.19 %) |
Aug 24 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Kinsella Kevin J | Director | Buy | P | 0.50 | 5,000 | 2,500 | 7,964,275 | 8 M to 8 M (+0.06 %) |
Aug 24 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Kinsella Kevin J | Director | Buy | P | 0.51 | 5,000 | 2,550 | 7,964,275 | 8 M to 8 M (+0.06 %) |
Aug 28 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Kinsella Kevin J | Director | Buy | P | 0.51 | 5,000 | 2,550 | 7,969,275 | 8 M to 8 M (+0.06 %) |
Aug 22 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Kinsella Kevin J | Director | Buy | P | 0.50 | 35,000 | 17,500 | 7,939,275 | 7.9 M to 7.9 M (+0.44 %) |
Aug 22 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Kinsella Kevin J | Director | Buy | P | 0.54 | 10,000 | 5,400 | 7,939,275 | 7.9 M to 7.9 M (+0.13 %) |
Aug 22 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Kinsella Kevin J | Director | Buy | P | 0.56 | 10,000 | 5,600 | 7,939,275 | 7.9 M to 7.9 M (+0.13 %) |
Aug 22 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Kinsella Kevin J | Director | Buy | P | 0.51 | 5,000 | 2,550 | 7,939,275 | 7.9 M to 7.9 M (+0.06 %) |
Aug 22 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Kinsella Kevin J | Director | Buy | P | 0.50 | 5,000 | 2,500 | 7,939,275 | 7.9 M to 7.9 M (+0.06 %) |
Aug 24 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Avalon Ventures VII L P | 10% Owner | Buy | P | 0.50 | 15,000 | 7,500 | 5,130,000 | 5.1 M to 5.1 M (+0.29 %) |
Aug 24 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Avalon Ventures VII L P | 10% Owner | Buy | P | 0.50 | 5,000 | 2,500 | 5,130,000 | 5.1 M to 5.1 M (+0.10 %) |
Aug 24 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Avalon Ventures VII L P | 10% Owner | Buy | P | 0.51 | 5,000 | 2,550 | 5,130,000 | 5.1 M to 5.1 M (+0.10 %) |
Aug 22 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Avalon Ventures VII L P | 10% Owner | Buy | P | 0.50 | 35,000 | 17,500 | 5,105,000 | 5.1 M to 5.1 M (+0.69 %) |
Aug 22 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Avalon Ventures VII L P | 10% Owner | Buy | P | 0.54 | 10,000 | 5,400 | 5,105,000 | 5.1 M to 5.1 M (+0.20 %) |
Aug 22 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Avalon Ventures VII L P | 10% Owner | Buy | P | 0.56 | 10,000 | 5,600 | 5,105,000 | 5.1 M to 5.1 M (+0.20 %) |
Aug 22 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Avalon Ventures VII L P | 10% Owner | Buy | P | 0.51 | 5,000 | 2,550 | 5,105,000 | 5.1 M to 5.1 M (+0.10 %) |
Aug 22 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Avalon Ventures VII L P | 10% Owner | Buy | P | 0.50 | 5,000 | 2,500 | 5,105,000 | 5.1 M to 5.1 M (+0.10 %) |
Aug 20 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Avalon Ventures VII L P | 10% Owner | Buy | P | 0.47 | 5,000 | 2,350 | 5,040,000 | 5 M to 5 M (+0.10 %) |
Aug 20 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Avalon Ventures VII L P | 10% Owner | Buy | P | 0.45 | 10,000 | 4,500 | 5,040,000 | 5 M to 5 M (+0.20 %) |
Aug 20 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Avalon Ventures VII L P | 10% Owner | Buy | P | 0.46 | 5,000 | 2,300 | 5,040,000 | 5 M to 5 M (+0.10 %) |
Aug 20 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Avalon Ventures VII L P | 10% Owner | Buy | P | 0.47 | 10,000 | 4,700 | 5,040,000 | 5 M to 5 M (+0.20 %) |
Aug 20 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Avalon Ventures VII L P | 10% Owner | Buy | P | 0.48 | 10,000 | 4,800 | 5,040,000 | 5 M to 5 M (+0.20 %) |
Aug 20 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Kinsella Kevin J | Director | Buy | P | 0.47 | 5,000 | 2,350 | 7,874,275 | 7.9 M to 7.9 M (+0.06 %) |
Aug 20 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Kinsella Kevin J | Director | Buy | P | 0.45 | 10,000 | 4,500 | 7,874,275 | 7.9 M to 7.9 M (+0.13 %) |
Aug 20 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Kinsella Kevin J | Director | Buy | P | 0.46 | 5,000 | 2,300 | 7,874,275 | 7.9 M to 7.9 M (+0.06 %) |
Aug 20 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Kinsella Kevin J | Director | Buy | P | 0.47 | 10,000 | 4,700 | 7,874,275 | 7.9 M to 7.9 M (+0.13 %) |
Aug 20 2007 | LBML.OB | AKESIS PHARMACEUTI ... | Kinsella Kevin J | Director | Buy | P | 0.48 | 10,000 | 4,800 | 7,874,275 | 7.9 M to 7.9 M (+0.13 %) |
Nov 24 2006 | LBML.OB | AKESIS PHARMACEUTI ... | Kinsella Kevin J | Director | Option Exercise | A | 0.60 | 750,000 | 450,000 | 750,000 | |
Nov 24 2006 | LBML.OB | AKESIS PHARMACEUTI ... | Kinsella Kevin J | Director | Buy | P | 0.60 | 5,000,000 | 3,000,000 | 5,000,000 | 0 to 5 M |
Nov 14 2006 | LBML.OB | AKESIS PHARMACEUTI ... | Lichter Jay | President and CEO | Option Exercise | A | 0.94 | 500,000 | 470,000 | 500,000 | |
Oct 24 2006 | LBML.OB | AKESIS PHARMACEUTI ... | SAYER KEVIN R | Director | Option Exercise | A | 0.94 | 50,000 | 47,000 | 50,000 | |
Oct 24 2006 | LBML.OB | AKESIS PHARMACEUTI ... | Hendrick John T | Chief Financial Off ... | Option Exercise | A | 0.94 | 50,000 | 47,000 | 50,000 | |
Apr 12 2006 | LBML.OB | AKESIS PHARMACEUTI ... | STEEL JOHN F IV | Director | Option Exercise | A | 3.00 | 8,750 | 26,250 | 8,750 | |
Apr 12 2006 | LBML.OB | AKESIS PHARMACEUTI ... | STEEL JOHN F IV | Director | Grant | A | 2.00 | 17,500 | 35,000 | 2,263,321 | 2.2 M to 2.3 M (+0.78 %) |
Apr 12 2006 | LBML.OB | AKESIS PHARMACEUTI ... | Kinsella Kevin J | Director | Option Exercise | A | 3.00 | 25,000 | 75,000 | 25,000 | |
Apr 12 2006 | LBML.OB | AKESIS PHARMACEUTI ... | Kinsella Kevin J | Director | Grant | A | 2.00 | 50,000 | 100,000 | 2,834,275 | 2.8 M to 2.8 M (+1.80 %) |
Jan 05 2006 | LBML.OB | AKESIS PHARMACEUTI ... | SAYER KEVIN R | Director | Option Exercise | A | 1.94 | 200,000 | 388,000 | 200,000 | |
Jan 05 2006 | LBML.OB | AKESIS PHARMACEUTI ... | Joy Kelly | V.P, Business Devel ... | Option Exercise | A | 1.94 | 200,000 | 388,000 | 200,000 | |
Aug 11 2005 | LBML.OB | AKESIS PHARMACEUTI ... | Fine Stuart A | 10% Owner | Gift | G | 0.00 | 2,027,197 | 0 | 0 | -2,027,197 to 0 (-100.00 %) |
Aug 11 2005 | LBML.OB | AKESIS PHARMACEUTI ... | Fine Stuart A | 10% Owner | Gift | G | 0.00 | 2,027,197 | 0 | 0 | 2 M to 0 (-100.00 %) |
Jan 25 2005 | LBML.OB | AKESIS PHARMACEUTI ... | Wilson Edward B | President & CEO | Option Exercise | A | 1.50 | 862,499 | 1,293,749 | 862,499 | |
Jan 25 2005 | LBML.OB | AKESIS PHARMACEUTI ... | Hendrick John T | Chief Financial Off ... | Option Exercise | A | 1.50 | 200,000 | 300,000 | 200,000 | |
Dec 21 2004 | LBML.OB | AKESIS PHARMACEUTI ... | STEEL JOHN F IV | Director | Grant | A | 0.00 | 2,249,291 | 0 | 2,249,291 | 4.5 M to 2.2 M (-50.00 %) |
Dec 17 2004 | LBML.OB | AKESIS PHARMACEUTI ... | Kinsella Kevin J | Director | Grant | A | 0.00 | 2,788,577 | 0 | 2,788,577 | 0 to 2.8 M |
Page: 1